Page last updated: 2024-11-06

floxuridine and Carcinoma, Signet Ring Cell

floxuridine has been researched along with Carcinoma, Signet Ring Cell in 3 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Carcinoma, Signet Ring Cell: A poorly differentiated adenocarcinoma in which the nucleus is pressed to one side by a cytoplasmic droplet of mucus. It usually arises in the gastrointestinal system.

Research Excerpts

ExcerptRelevanceReference
"Whether gastric cancer in young adults differs from gastric cancer in older patients has been a controversial issue."2.41Gastric cancer in very young adults: apropos four patients and a review of the literature. ( Fiehler, J; Höffken, K; Kath, R; Schneider, CP, 2000)
"Type 3 gastric cancer in the midgastric region was diagnosed, and the patient underwent surgery."1.33[A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy]. ( Fukasawa, T; Gotoh, H; Shoji, T; Taniwaka, K, 2006)
"She was diagnosed as having an advanced gastric cancer, which was unresectable because of liver metastasis, esophageal invasion and paraaortic lymph node metastasis."1.29[Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report]. ( Hoshino, K; Ikeda, H; Kamoshita, N; Kobayashi, J; Koyama, T; Morishita, Y; Nakamura, M; Tanaka, T, 1996)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukasawa, T1
Shoji, T1
Gotoh, H1
Taniwaka, K1
Hoshino, K1
Nakamura, M1
Kamoshita, N1
Ikeda, H1
Kobayashi, J1
Tanaka, T1
Koyama, T1
Morishita, Y1
Kath, R1
Fiehler, J1
Schneider, CP1
Höffken, K1

Reviews

1 review available for floxuridine and Carcinoma, Signet Ring Cell

ArticleYear
Gastric cancer in very young adults: apropos four patients and a review of the literature.
    Journal of cancer research and clinical oncology, 2000, Volume: 126, Issue:4

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cis

2000

Other Studies

2 other studies available for floxuridine and Carcinoma, Signet Ring Cell

ArticleYear
[A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Combined Modality Thera

2006
[Unresectable gastric cancer followed by remarkably effective tumor disappearance and good quality of life for 10 months after CDDP/5'-DFUR combination chemotherapy--a case report].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:13

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Esoph

1996